News
VERO
0.6100
-9.98%
-0.0676
Weekly Report: what happened at VERO last week (0408-0412)?
Weekly Report · 20h ago
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
Venus Concept's first quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 15, 2024. The company is a global medical aesthetic technology leader. Venus Concept is a subsidiary of Venus Concept Inc. The company's shares will be listed on Nasdaq.
Barchart · 1d ago
Venus Concept files to sell 1.64M shares of common stock for holders
Venus Concept files to sell 1.64M shares of common stock for holders. Venus Concept (NASDAQ:VERO) filed a prospectus related to the resale by the selling stockholders of up to 1,644,400 shares. This prospectus is not an offer to sell.
Seeking Alpha · 04/08 21:29
VENUS CONCEPT -FILES PROSPECTUS RELATES TO RESALE, FROM TIME TO TIME, BY SELLING STOCKHOLDERS OF UP TO 1.6 MLN SHARES OF COMMON STOCK
Reuters · 04/08 21:21
Venus Concept gets approval from Israel regulators for Venus Bliss MAX
Venus Concept gets approval from Israel regulators for Venus Bliss MAX. The company's shares rose 3% in pre-market trade. Venus Concept first launched the Venus BlissMAX commercially in the U.S. In Q1 2022. The company got approval from the State of Israel Ministry of Health.
Seeking Alpha · 04/08 11:43
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Venus Concept has received approval for the Venus Bliss MAX from the State of Israel Ministry of Health. The Venus BlissMAX will be first launched commercially in the United States in Q1 2022. The company is a global medical aesthetic technology leader. The company has received FDA 510(k) clearance.
Benzinga · 04/08 11:31
VENUS CONCEPT INC: HAS RECEIVED APPROVAL FOR VENUS BLISS MAX FROM STATE OF ISRAEL MINISTRY OF HEALTH
Reuters · 04/08 11:30
Weekly Report: what happened at VERO last week (0401-0405)?
Weekly Report · 04/08 11:01
Venus Concept files to sell 874,990 shares for holders
Venus Concept files to sell 874,990 shares for holders of its common stock. The company filed a prospectus related to the proposed resale of about 874,.990 shares of its stock. Venus Concept Inc. (VERO) Stock. The company has filed the prospectus.
Seeking Alpha · 04/03 20:59
Analysts Offer Insights on Healthcare Companies: High Tide (HITI), Venus Concept (VERO) and Immunocore Holdings (IMCR)
Companies in the Healthcare sector have received a lot of coverage today. High Tide, Venus Concept and Immunocore Holdings have been reiterated by analysts today. Venus Concept has an analyst consensus of Hold while Immunocores Holdings has a Buy rating. The company's shares closed at $2.30 today.
TipRanks · 04/03 11:40
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
Venus Concept has Therapeutic Goods Administration clearance in Australia to market the Venus Versa Pro system. The system combines the applicator of the Venus Viva MD with the VenusVersa system. Both are approved in Australia and registered in the Australian register of therapeutic goods.
Barchart · 04/03 06:30
BTIG Sticks to Its Hold Rating for Venus Concept (VERO)
TipRanks · 04/02 09:09
Venus Concept’s Operations Under Threat: Geopolitical Tensions in Israel Pose Risks to Business Continuity
TipRanks · 04/02 06:01
VERO Stock Earnings: Venus Concept Misses EPS, Misses Revenue for Q4 2023
Venus Concept reported earnings per share of -$2.01 for the fourth quarter of 2023. The company reported revenue of $18.13 million. This was 19.23% worse than the analyst estimate for revenue in the same period. Venus Concept reported results for the last quarter of 2013.
Investorplace · 04/01 15:53
*Venus Concept Sees 1Q Rev $16.5M >VERO
Dow Jones · 04/01 11:05
Venus Concept GAAP EPS of -$2.01, revenue of $18.13M
Seeking Alpha · 04/01 11:03
VENUS CONCEPT INC: TOTAL REVENUE OF $18.1 MLN, DOWN $6.2 MLN
Reuters · 04/01 11:00
VENUS CONCEPT INC: QTRLY SHR LOSS $2.01
Reuters · 04/01 11:00
VENUS CONCEPT ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS
Reuters · 04/01 11:00
*Venus Concept 4Q Loss $11.1M >VERO
Dow Jones · 04/01 11:00
More
Webull provides a variety of real-time VERO stock news. You can receive the latest news about Venus Concept Inc through multiple platforms. This information may help you make smarter investment decisions.
About VERO
Venus Concept Inc. is a global medical aesthetic technology company. The Company has a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches in over 60 countries and 14 direct markets. The Company's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. The Company's systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry's traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company's hair loss treatment solutions include the ARTAS Solution and the NeoGraft Solution.